6ZB.F LINC AB

Financial Services Capital Markets Frankfurt Exchange
6.31 EUR
Close of Nov 11, 2026
5.52 7.01
Market cap
EUR 363M
P/E
57.4x
P/B
0.87x
ROE
5.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 6ZB.F undervalued?

Graham number
Price6.31
Graham value4.23
Premium49.3%

6ZB.F trades 49.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LINC AB fundamental analysis

No fundamental analysis for LINC AB yet.

LINC AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LINC AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually…

Full company profile